Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Jack R. Andrews"'
Autor:
Mohamed E. Ahmed, Ahmed M. Mahmoud, Guiseppe Reitano, Wael Zeina, Kelly Lehner, Carter A. Day, Irbaz Riaz, Daniel S. Childs, Jacob J. Orme, A. Tuba Kendi, Geoffrey B. Johnson, R. Jeffrey Karnes, Eugene D. Kwon, Jack R. Andrews
Publikováno v:
European Urology Open Science, Vol 66, Iss , Pp 38-45 (2024)
Background and objective: Visceral metastatic disease in prostate cancer patients conveys a poor prognosis. Using advanced imaging techniques, studies have demonstrated increasing detection rates of visceral metastasis. Visceral metastases are now se
Externí odkaz:
https://doaj.org/article/8d4eb652bd404f21a76df8cc20d2d208
Autor:
Ahmed M. Mahmoud, Mohamed E. Ahmed, A. Tuba Kendi, Matthew Thorpe, Geoffrey B. Johnson, Irbaz Bin Riaz, Jacob J. Orme, Eugene D. Kwon, Jack R. Andrews, Daniel S. Childs
Publikováno v:
BJUI Compass, Vol 5, Iss 2, Pp 319-324 (2024)
Abstract Background For men with prostate cancer, radiographic progression may occur without a concordant rise in prostate‐specific antigen (PSA). Our study aimed to assess the prevalence of radiographic progression using C‐11 choline positron em
Externí odkaz:
https://doaj.org/article/29b24f73a0de43fead3611b2e5a728e1
Autor:
Ahmed M. Mahmoud, Amr Moustafa, Carter Day, Mohamed E. Ahmed, Wael Zeina, Usama M. Marzouk, Spyridon Basourakos, Rimki Haloi, Mindie Mahon, Miguel Muniz, Daniel S. Childs, Jacob J. Orme, Irbaz Bin Riaz, A. Tuba Kendi, Bradley J. Stish, Brian J. Davis, Eugene D. Kwon, Jack R. Andrews
Publikováno v:
Cancers, Vol 16, Iss 11, p 2080 (2024)
Prostate cancer lung metastasis represents a clinical conundrum due to its implications for advanced disease progression and the complexities it introduces in treatment planning. As the disease progresses to distant sites such as the lung, the clinic
Externí odkaz:
https://doaj.org/article/1f25d022c1a94c2a86f7fdbced52f527
Autor:
Mohamed E. Ahmed, MB, BCh, Jack R. Andrews, MD, Vidhu B. Joshi, BSc, Lance A. Mynderse, MD, Matthew K. Tollefson, MD, R. Jeffrey Karnes, MD, Eugene D. Kwon, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 3, Pp 689-692 (2021)
Externí odkaz:
https://doaj.org/article/33f61aaabfef4771a630b1ea6047eb77
Autor:
Jack R. Andrews, MD, Mohamed E. Ahmed, MB, BCh, Giovanni Motterle, MD, Sam T. Albadri, MD, Rimki Haloi, R. Jeffrey Karnes, MD, Eugene D. Kwon, MD, Katharine A. Price, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 5, Pp 601-607 (2020)
A 62-year-old man presented with a rising serum concentration of prostate-specific antigen (PSA) to 53.3 ng/mL (to convert to μg/L, multiply by 1) and a PSA doubling time of 2.6 months. Computed tomography, fluorodeoxyglucose–positron emission tom
Externí odkaz:
https://doaj.org/article/e468b8e564154f18ae32bee0244823cf
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Patients diagnosed with clinically node-positive prostate cancer represent a population that has historically been thought to harbor systemic disease. Increasing evidence supports the role of local therapies in advanced disease, but few studies have
Externí odkaz:
https://doaj.org/article/c47f9d1bdf0a4964a8c11695f1af13a3
Autor:
Cameron J. Britton, Jack R. Andrews, Christopher J.D. Wallis, Vidit Sharma, Bradley C. Leibovich, R. Houston Thompson, Stephen A. Boorjian, Bimal Bhindi, Brian A. Costello
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 41:125-136
Autor:
Jamal Alamiri, Cameron J. Britton, Mohamed E. Ahmed, Jack R. Andrews, Julianna L. Higa, Ayca Dundar, R. Jeffrey Karnes, Eugene Kwon, Val J. Lowe, Ayse T. Kendi, Michael S. Bold, Lance C. Pagliaro
Publikováno v:
The Prostate. 82:1483-1490
Prostatic specific antigen (PSA) has well-recognized limitations as a marker for treatment response and disease progression. Post hoc analysis of the PREVAIL trial reported 24.5% of chemotherapy naïve metastatic castration-resistant prostate cancer
Publikováno v:
Journal of Urology.
Autor:
Akshay Sood, Ralph Grauer, Mireya Diaz-Insua, Ashutosh K. Tewari, Ashok K. Hemal, Alok Shrivastava, James O. Peabody, Wooju Jeong, Firas Abdollah, Jan K. Rudzinski, Jack R. Andrews, Michael A. Gorin, Mahendra Bhandari, Mani Menon
Publikováno v:
Prostate Cancer and Prostatic Diseases.